LOS ANGELES, Feb. 4, 2025 — Today, Aguileros Beverage Group, is pleased to announce the debut of their newly-launched private equity fund focused on Mexican and beverage alcohol-specific opportunities, providing more than just funding by also offering growth solutions through strong relationships and operational expertise.

The Aguileros Fund is looking to raise $5M with a $10M hard cap, with $2M in commitments secured thus far with a fund life of 10 years following first close. The group will invest following three main criteria pillars: Minority investments in high-growth potential companies, Seed capital for new and emerging businesses, and Strategic partnerships in established businesses that can also benefit from restructuring.

Started by Alex Staniloff, Eli Diamond and Abe Cortes, the fund is comprised of highly experienced investors, operators and entrepreneurs, with notable track records across relevant verticals of the wider beverage industry.

Their roster of General Partners span North American geographics, including Canada, Los Angeles, New York City and Guadalajara, many of whom have launched companies of their own as well as having been part of multiple exits totaling over $300M. The team also has established a distribution agency covering Canada nationwide in addition to having built award-winning branding and marketing agencies.

“We believe the time is now to invest in the wider Mexican beverage category and have developed a behemoth group of experts who can take these brands to uncharted new heights in 2025 and beyond through the launch of our fund – Aguileros Venture Fund II, states Alex Staniloff, General Partner and Managing Member.

The team’s extensive group of advisors all come from strong and diverse backgrounds bringing another layer of credibility and connections across the world.

One of the biggest challenges in Mexico’s beverage space is gaining real access to early-stage brands. Many of the most promising opportunities remain insulated within local networks, making it difficult for traditional investors to engage at the right time. Aguileros’ deep-rooted presence in Guadalajara, Mexico City, and across North America provides an unparalleled advantage, granting the fund early access to emerging brands before they hit the mainstream.

Backing this strategy is a world-class advisory team with expertise spanning private equity, operations, brand building, distribution, and finance. The team includes:

• Arnie Fridhandler, a private equity partner at Weil, Gotshal & Manges LLP (New York, NY), offering deep M&A and structuring expertise.
• Taylor Foxman, founder of The Industry Collective (New York, NY), known for leading beverage brand strategy and successfully scaling brands to exit.
• Steven Roopenian, Principal at Grobstein Teeple LLP (Los Angeles, CA), bringing financial diligence and restructuring experience.
• Mack Zavitz, General Manager at The Beverage Collective (Toronto, ON), providing extensive distribution and route-to-market knowledge.
• Esteban Morales, founder of Casa Endémica (Guadalajara, MX), specializing in production and supply chain operations within Mexico’s spirits industry.
• Hector Banda, founder of IGL Mexico (Guadalajara, MX), with deep insights into logistics and distribution in Mexico’s beverage market.
• Alan Mulvihill, a key figure in El Gallo Altanero, Roe & Co, and Diageo, offering global brand-building expertise.

Among the fund’s leadership, Eli Diamond, General Partner, Operations, brings a wealth of experience in the Mexican spirits sector. As a board member of the Additive Free Alliance (Tequila Matchmaker), he has been at the forefront of advocating for transparency and authenticity in the tequila industry, working alongside top brands to ensure quality and integrity in production. Eli was also part of the founding team of Ole Cocktail Co., where he played a key role in the brand’s successful launch and distribution rollout, ultimately leading to its acquisition by Mark Anthony Group before its U.S. entry. His expertise in operations, partnerships, and brand growth makes him a critical asset in Aguileros’ ability to identify, nurture, and scale promising brands.

To learn more about getting involved in the current raise, please reach out to Alex Staniloff directly at [email protected].

Media Contact:
Taylor Foxman
609-432-2237

SOURCE Aguileros Beverage Group

AUSTIN, Texas, Feb. 4, 2025 — Boxsy, the AI-driven operational hub for startups and their ecosystems, launches to the public today, providing founders, investors, and advisors with tools to eliminate operational burdens and focus on growth. With features designed to streamline workflows and deliver actionable insights, Boxsy empowers its users to scale their businesses with greater efficiency and clarity.

Boxsy offers solutions that cater to the needs of startups and their key stakeholders:

• Startup Solution: Empowers founders and entrepreneurs to focus on strategic growth by reducing time spent on daily operations, providing clear financial visibility, and offering access to trusted experts for seamless scaling.
• Investor Solution: Enables investors to make informed decisions with real-time portfolio analytics, proactively manage risks, and strengthen relationships with startups.

“Scaling a startup shouldn’t feel like reinventing the wheel every day,” said Elisabeth Bykoff, Founder and CEO of Boxsy. “We created Boxsy to act as a strategic partner—one that simplifies the complexities of running a business while unlocking opportunities for growth. Whether you’re a founder driving innovation or an investor seeking clarity, Boxsy is here to make the journey smoother and more impactful.”

Boxsy’s AI-driven analytics not only streamline operations but also predict potential challenges before they arise, enabling founders to proactively address issues and maintain momentum. The platform features pre-built dashboards, cash flow monitoring, operational playbooks, and access to a curated marketplace of expert service providers.

Beyond serving founders, Boxsy fosters a connected ecosystem by facilitating seamless communication between investors, advisors, and startups. Investors get a robust toolkit to track portfolio health, reduce risks, and foster collaboration with startups through real-time insights and customizable reporting.

Boxsy’s AI-powered operational platform is now available for general use. Startups can experience its capabilities firsthand with a free 7-day trial. Visit www.boxsy.io to get started.

About Boxsy

Boxsy is on a mission to empower startups and the entire ecosystem by providing a seamless operational hub designed to make entrepreneurship more successful. Our vision is to simplify the operational complexities that often hinder growth, offering founders and their partners the tools, insights, and connectivity they need to thrive. From streamlined reporting to expert-backed solutions, Boxsy is here to help startups scale smarter and build stronger, more impactful businesses.

Media Contact
Alastar Kerpel
Boxsy
[email protected]
510-697-7484

SOURCE Boxsy

EINDHOVEN, The Netherlands, Feb. 4, 2025 — As World Cancer Day is observed, Dutch medical device company Sirius Medical, the leader in surgical marker navigation, announced securing 10M€ in additional scale-up funding. This investment round was led by Invest-NL and Nextgen Ventures, with support from De Groot Family Office and existing investors Brabant Development Agency (BOM), Holland Capital, Curie Capital, Team Holmium, and Sirius Medical’s team.

World Cancer Day is a poignant reminder of the ongoing fight against cancer, and this milestone reflects Sirius Medical’s commitment to enhancing cancer care. Praised by breast cancer surgeons worldwide, the Sirius Pintuition^® surgical navigation platform enables simple, best-in-class, wire-free localization for breast-conserving surgery in any hospital. This latest funding round empowers Sirius Medical to enhance the Sirius Pintuition system and GPSDetect^™ software platform, focusing on usability and intuitiveness, and extending its applications. Additionally, the investment will substantially bolster the sales infrastructure and support expansion into new markets.”

“At Invest-NL our healthcare focus is on investing in innovations that aim to avoid, replace, or relocate expensive care,” Karin Steffens, senior investment manager at Invest-NL commented. “Sirius Medical’s mission to develop sustainable technology solutions while maintaining balance within the healthcare system closely aligns with our mission to accelerate the healthcare transition. We are excited to back a company making such a meaningful difference for women with breast cancer.”

“Announcing this funding milestone on World Cancer Day underscores the urgency of our mission to improve cancer care globally,” says Bram Schermers, CEO of Sirius Medical. “This funding round, in the current fundraising environment, is a clear testament to the talent of the Sirius Medical team, and the Pintuition technology that we have developed. We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical. We will have more exciting news to announce soon.”

“The Sirius Medical leadership team has shown exceptional expertise and adaptability,” stated Roel Dekkers, Investment Manager, NextGen Ventures. “The company is well positioned for expansion, and we see a tremendous opportunity for growth in untapped markets.”

About World Cancer Day
World Cancer Day, observed on February 4th, is a global initiative to raise awareness and inspire action to work together to reduce the impact of cancer worldwide.

About Sirius Medical

With its roots in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. Sirius Pintuition is precise, simple, affordable, and both CE marked, and FDA cleared. Sirius Medical is rapidly expanding with over 250 centers and 35.000 procedures globally.

www.sirius-medical.com | @SiriusMedical | #siriuspintuition

Benjamin Tchang – Corporate contact 
[email protected] 
+31 857 732 727 (The Netherlands)

SOURCE Sirius Medical

As Evolving Drone Threats Continue to Intensify, Hidden Level Sees Strategic Growth as it Executes on a Number of U.S. Government Contracts  

SYRACUSE, N.Y., Feb. 3, 2025 — Hidden Level, a leader in passive radar and radio frequency sensing technology for detecting and precisely locating drones and other threats around you, today announced $65 million in Series C funding led by DFJ Growth with participation from Booz Allen Ventures, Revolution Growth, Costanoa Ventures, Washington Harbour Partners, Veteran Ventures, Founders Circle Capital, and others. This investment comes on the heels of the company’s $35 million Series B which closed only 6 months prior, bringing the company’s funding over the last 12 months to $100M, solidifying its position as a robust technology player in the rapidly evolving national security and critical infrastructure landscape.

The rapid proliferation of unmanned aerial systems (UAS) has introduced significant challenges to national security and the protection of critical infrastructure for the U.S. and its allies. From espionage to the potential for hostile actions, drones represent a growing threat in both military and civilian environments. As drones become increasingly sophisticated, with smaller sizes, enhanced stealth capabilities, and the ability to operate in swarms, traditional radar systems often struggle to provide reliable detection and tracking. This gap in airspace situational awareness underscores the urgent need for advanced sensing solutions capable of identifying and locating drone threats in real-time, even in complex and congested electromagnetic environments, to protect public safety and critical infrastructure.

Hidden Level detects and tracks a wide range of aerial activity, including drones—whether emitting signals, operating covertly as dark drones, or posing as imitations—along with aircraft, balloons, and other objects in the airspace. Its advanced technology also pinpoints the location of drone operators, providing a comprehensive and actionable view of aerial activity. Crucially, Hidden Level achieves this while maintaining full compliance with Title 18 regulations, safeguarding privacy and avoiding the need for changes to existing legislation.

Hidden Level’s technology is increasingly recognized for its necessity in high-security scenarios. The company is on contract this year to support technology deployments for the U.S. Army, U.S. Air Force, U.S. Africa Command, U.S. Indo-Pacific Command, U.S. Central Command, U.S. Northern Command, and other federal, state and local agencies, to address drone threats to U.S. national security, critical infrastructure, and military bases. The company’s technology has been deployed to monitor major events, such as the recent presidential inauguration, where airspace security is critical.

Hidden Level’s innovative approach is powered by its passive radar and RF direction-finding technology, which remains undetectable to bad actors, ensuring strategic sensor placement and uninterrupted operations. By leveraging its vertically integrated design, manufacturing, and testing capabilities, the company delivers sensors optimized for cost, mobility, performance, and spectrum breadth, meeting the diverse needs of its customers. Hidden Level’s scalable solutions—whether delivered as hardware or data-as-a-service—offer unmatched flexibility and utility in monitoring low and high-altitude airspace.

“Hidden Level is addressing a critical gap in our defense capabilities with advanced technologies that identify and track the proliferating UAS threats, while remaining virtually undetectable”, said Randy Glein from DFJ Growth. “This capability is changing the game on the battlefield, providing an electronic surveillance shield for our forces and assets in harm’s way.” 

Hidden Level’s team brings deep expertise in advanced sensing technology honed through experience with the DoD, aviation authorities, and NASA.

“Critical infrastructure is the backbone of our nation’s security,” said Jeff Cole, co-founder and CEO of Hidden Level. “Today’s evolving threats demand comprehensive airspace monitoring, from low-altitude drones to high-altitude aircraft and everything in between. With this new funding, we are poised to expand our impact, enhancing defense capabilities and supporting public safety, critical infrastructure, and emerging commercial needs.”

The new capital will be used to scale the business by expanding manufacturing, hiring across the board, and growing internationally after successful deployments with over a dozen cutting-edge customers, including NASA, the U.S. Army, the U.S. Air Force, and the U.S. Department of Defense, while meeting the demands of new clients.

The Series C round follows the company’s $30M Series B funding in 2024 led by Lauder Partners with participation from Booz Allen Ventures, Washington Harbour Partners, Veteran Ventures, Valor Equity, and others.

About Hidden Level
Founded in 2018, Hidden Level is a leader in advanced airspace monitoring and drone detection technology, dedicated to securing critical infrastructure and addressing emerging national security threats. Hidden Level’s innovative solutions provide real-time, actionable insights by detecting and tracking a wide range of aerial activity, including low-altitude drones, high-altitude aircraft, balloons, and other airborne objects, as well as their operators.

Leveraging passive radar and RF direction-finding technology, Hidden Level ensures privacy protection while empowering federal, state, and local agencies with unparalleled situational awareness. The company’s vertically integrated approach to product design, manufacturing, and testing enables scalable, cost-effective deployments tailored to the diverse needs of its customers.

Backed by leading investors, including DFJ Growth, Lauder Partners, Revolution Growth, Booz Allen Ventures, Costanoa Ventures, Washington Harbour, Valor Equity, and Veteran Ventures, Hidden Level continues to drive innovation at the intersection of technology and national security.

For more information, visit hiddenlevel.com or follow Hidden Level on LinkedIn.

About DFJ Growth 
DFJ Growth is a prominent investor in emerging technology leaders during their scaling phase of development. Founded in 2005, DFJ Growth partners with extraordinary, mission-driven entrepreneurs disrupting the status quo with game-changing innovations that become iconic companies. Our investments include Anaplan, Anduril, Box, Cellares, Coinbase, Commonwealth Fusion Systems, Neuralink, OpenAI, Patreon, Ring (Amazon), ScaleAI, SolarCity (Tesla), SpaceX, Stripe, Tesla, Twitter, Ring, Unity, and xAI. DFJ Growth is a fearless investor and steadfast partner to founders who imagine the future and execute on the hv ir bold visions to define it.

Press Contact: 
Mary Devincenzi
408-761-4285
[email protected]

SOURCE Hidden Level, Inc.

This new program provides an excellent opportunity to bolster the state’s economy.

PORTLAND, Ore., Feb. 3, 2025 — Elevate Capital, Oregon’s first inclusive venture capital fund supporting diversity and inclusion, has been selected by Business Oregon to manage the SSBCI (State Small Business Credit Initiative) Venture Direct program. This selection marks a significant advancement for Oregon’s early-stage startups.

“The honor of managing the SSBCI Venture Direct program follows a highly competitive selection process with Business Oregon and reflects Elevate Capital’s reputation and effectiveness in fostering innovation and growth in Oregon’s startup community with investment. We are thrilled to receive the continued trust and confidence from the State of Oregon,” says Nitin Rai, Elevate Capital’s Founder and Managing Partner.

“This recognition builds on Elevate Capital’s successful track record managing the Gap Fund I and Gap Fund II, also backed by Business Oregon. Our team has demonstrated a strong commitment to nurturing emerging businesses, and this new program provides an excellent opportunity to bolster the state’s economy,” says Ben Nahir, Venture Principal, Elevate Capital.

Funding Requirements

• The SSBCI Venture Direct program will allocate up to $15M to invest in Oregon startups over the next four to six years.
• Elevate will catalyze additional investment opportunities into Oregon startups, as each SSBCI investment requires at least a 1:1 match at the time of investment.
• The SSBCI portfolio will include at least 40% SEDI (socially and economically disadvantaged individuals) -owned businesses.
• This Fund will invest in all new companies.

About Elevate Capital

Founded in 2016, Elevate Capital is the nation’s first institutional venture capital fund primarily targeting investments in underrepresented entrepreneurs, including women, BIPOC, LGBTQ+ communities, and those with limited regional access to capital and opportunities. Through the Innovation Gap Funds, Elevate supports high-risk research-driven innovation in Oregon by investing at the earliest stages in startups from healthcare, life sciences, cleantech, sustainability, and other target-traded sector industries. Visit elevate.vc or follow Elevate Capital on X, Facebook, and LinkedIn.

SOURCE Elevate Capital

Affineon Health Expands AI Inbox to Tackle Provider Burnout, Improve Patient Care

DENVER, Feb. 3, 2025 — Affineon Health, a leader in AI-powered solutions to streamline the inbox for healthcare physicians and providers, today announced successfully closing a $5 million oversubscribed funding round. GPG Ventures led the seed round with participation from existing investor, AI Fund, and several other new investors.

The funding enables Affineon to accelerate product development, expand its fast-growing market presence, and deepen its impact on one of healthcare’s most pressing challenges: the administrative burden on providers that’s a leading cause of physician burnout.

“We’re empowering healthcare providers by automating tedious tasks so they can spend more time on patient care and less on administrative work,” said David Norris, Co-Founder and CEO of Affineon Health. “This oversubscribed round underscores how important solving this problem is and positions Affineon to scale our AI inbox to improve even more lives.”

Transforming Provider Inboxes with AI
By automating routine lab results, prescription renewals, and patient communications, Affineon reduces inbox volume up to 80% and saves providers over five hours per week, while improving response times and the patient experience. Seamlessly integrated with electronic health record (EHR) systems, providers reclaim their time in Affineon’s AI inbox without disrupting existing workflows.

Investor Perspectives
“By slashing the time doctors spend wrangling their inbox, Affineon reduces a major healthcare pain point,” said Claire England, Investment Partner at GPG Ventures. “We’re thrilled to back this experienced team’s innovative AI inbox and their dedication to improving physician efficiency and patient care.”

“The healthcare industry is hungry for solutions that combine advanced AI technology with practical applications,” said Matt Miller, Managing Partner at Headwater Ventures. “The administrative burden physicians face every day is why we invested in Affineon, with its unique AI inbox solution”

Other new investors in this round include Deepwater, Benhamou Global Ventures (BGV), Headwater Ventures, and Signal Peak Ventures. Together with GPG Ventures and AI Fund, their support reflects solid investor confidence in Affineon’s market leadership and momentum. This round brings Affineon’s total capital raised to $6 million.

Accelerating Momentum

The funding builds on Affineon’s recent achievements, including:

• Market traction: Partnering with leading health systems, physician practices, and EHRs like athenahealth.
• Innovation: Advancing AI-powered tool development for lab results, Rx renewals, and patient communication.
• Recognition: Establishing itself as an essential innovator reducing provider burnout and improving patient care.

About Affineon Health
Affineon Health’s AI inbox streamlines provider workflows and eases administrative burdens. Its flagship solutions improve efficiency, reduce burnout, and help healthcare providers focus on delivering high-quality patient care. Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience.

About the Investors
GPG Ventures is a Texas-based healthcare VC firm. With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech. Individual and family office LPs have invested alongside the firm’s partners in more than 100 portfolio companies since 2011.
AI Fund is a venture studio that strives to move humanity forward by accelerating the adoption of AI. Acting as a minor co-founder, AI Fund partners with entrepreneurs to form new companies together. AI pioneer Andrew Ng launched AI Fund in 2018 with $176 million from top-tier firms such as Greylock, NEA, Sequoia, and Softbank Group.
Deepwater Asset Management manages equity investment funds across the growth spectrum in public and private markets. They seek to invest in transformative technologies and innovators that will unlock value for their investment partners.
Benhamou Global Ventures (BGV) is a cross-border VC firm with deep roots in Silicon Valley and a focus on global Enterprise 5.0 AI technology innovation.
Headwater Ventures is a Minneapolis-based VC firm investing in tech founders building the next generation of category-defining healthcare companies.
Signal Peak Ventures is a Salt Lake City-based VC firm investing in technology companies in emerging markets, primarily outside of Silicon Valley.

Media Inquiries:
Affineon Health
Marc Feder
[email protected]
www.affineon.com

SOURCE Affineon Health

Flyover Capital, SineWave Ventures lead funding round, former Chief of NSA’s Trusted Systems Research Group joins board

LAWRENCE, Kan., Feb. 3, 2025 — Invary, a pioneer in Runtime Integrity solutions, successfully raised a $3.5 million Seed funding round from SineWave Ventures, Flyover Capital, Hyperlink Ventures, and KCRise Fund. This funding enables Invary to advance its mission of verifying the Runtime Integrity of entire systems, ensuring comprehensive confidentiality and security.

Invary’s patented solutions, powered by technology exclusively licensed from the National Security Agency (NSA), are leading a paradigm shift in confidential computing, bringing advanced runtime security already deployed in high-assurance federal entities to the commercial sector. Join Invary and federal and commercial experts in a live webinar February 24th to learn more.

Dr. Patricia Muoio, General Partner at SineWave Ventures and former Chief of NSA’s Trusted Systems Group, is joining Invary’s Board of Directors. Muoio brings deep expertise in cybersecurity, emerging technologies, and strategic planning across both federal and commercial sectors.

“It is time for enterprises to stop letting attackers dictate the rules of the game, instead capitalizing on having home-field advantage,” said Dr. Muoio. “Invary’s Runtime Integrity solution is an important technology for any enterprise looking to enhance their security posture.”

The seed funding will accelerate the launch of Invary’s Windows Kernel Runtime Integrity solution and groundbreaking eBPF Runtime Integrity verification, complementing its established Linux Runtime Integrity solution. Invary’s technology additionally supports verifying Trusted Execution Environments (TEE), such as AMD’s SEV-SNP, ensuring systems remain uncompromised at runtime. These offerings provide continuous state-based verification of vital layers core to security, enabling customers to detect sophisticated threats and zero-day malware that are invisible to other threat detection mechanisms.

“By successfully validating critical government systems, Invary has demonstrated its capability to address some of the most demanding challenges in system security. Invary is experiencing growing interest from the private sector, further fueled by its upcoming launch of Runtime Integrity for Windows,” said Dan Kerr, Partner at Flyover Capital. “The real-time system integrity approach pioneered by Invary has the potential to redefine how industries think about and implement security in the years ahead.”

Flyover Capital, which also led Invary’s Pre-Seed round, has reinforced its support in this funding round, underscoring its strong belief in Invary’s groundbreaking capabilities and the urgent need for its technology in today’s rapidly evolving cybersecurity landscape.

“Invary is redefining runtime security with our upcoming eBPF Runtime Integrity solution,” said Jason Rogers, CEO of Invary. “Researched in part with the NSA’s Trusted Mechanisms group under a CRADA, this solution extends basic built-in BPF protections, ensuring that eBPF programs and their data remain unaltered in memory at runtime. Combined with our Windows and Linux Kernel Runtime Integrity solutions and runtime TEE attestation, we are bringing the confidentiality and security trusted by high-assurance federal systems to the commercial market.”

Leading federal and commercial organizations trust Invary to strengthen Zero Trust Architectures by verifying runtime integrity and eliminating the foundational assumptions on which security postures are built.

“At Spencer Fane, safeguarding our data is our highest priority,” said Wai Sheng Cheng, Head of Security for Spencer Fane. “Invary’s ability to verify the confidentiality and security of our systems at runtime represents a significant advancement in protection. By reinforcing the foundation of our security posture, Invary enhances our ability to protect our critical data.”

Invary’s technology is seamlessly integrated into partner solutions, as demonstrated by its incorporation into Vibrint’s enterprise solution offerings. For example, this collaboration brings Invary’s advanced Runtime Integrity solutions to Vibrint’s high-performance computing (HPC) offering, delivering the level of confidentiality and assurance that national security customers demand.

“We are excited to be working with Invary,” said Scott Clark. “Their unique technology is helping Vibrint elevate our Zero Trust solutions, enabling our customers to gain a stronger advantage in achieving their national security missions. We look forward to building on this collaboration and exploring new ways to drive innovation together.”

With its Runtime Integrity solutions, Invary protects critical systems against tampering, persistence, and hidden threats by continuously measuring and verifying system behavior at runtime. By delivering solutions for Linux, Windows, eBPF, and Trusted Execution Environments, Invary ensures that organizations can operate with confidence across the entire technology stack.

About Invary

Invary delivers industry-leading Runtime Integrity solutions that ensure the security and confidentiality of critical systems. Built on NSA-licensed technology, Invary provides comprehensive protection for Linux, Windows, eBPF, and Trusted Execution Environments. By continuously verifying runtime integrity, Invary safeguards systems against tampering and advanced threats, enabling Zero Trust Architectures across federal and commercial sectors.

For more information, visit [www.invary.com].

About SineWave Ventures

SineWave Ventures is a leading venture capital firm that bridges the gap between innovative startups and established enterprises, with a particular focus on fostering connections with government agencies and the public sector. By investing in transformative technologies and solutions, SineWave empowers early-stage companies to scale and make meaningful impacts across industries. With deep expertise, a robust network, and a commitment to driving progress, SineWave serves as a catalyst for growth, helping startups navigate complex markets and achieve sustainable success.

For more information, visit [https://sinewave.vc/].

About Flyover Capital 

Flyover Capital is a leading early-stage venture capital firm dedicated to creating the next generation of technology success stories outside the traditional tech hubs. The firm invests in transformative companies and venture funds across industries such as cybersecurity, FinTech, InsurTech, privacy and security, dual-purpose tech, and productivity solutions. Flyover’s portfolio reflects its commitment to solving critical challenges and fostering innovation that drives economic growth. By leveraging its deep expertise and extensive network, Flyover Capital supports the development of groundbreaking solutions that redefine industries and create lasting impact.

For more information, visit [https://www.flyovercapital.com/].

About Vibrint

Vibrint helps national security customers Make the Right Call, sustaining mission advantage at the forefront of intelligence gathering and analysis. Our teams of technologists, analysts and mission specialists pursue innovation in high-performance computing, SIGINT research and analysis, software and systems development, and mission resilience. The systems we create and the services we provide enhance our customers’ capacity and capability for harvesting and harnessing data, enhancing the quality and speed of mission-critical decisions. Within our Collaboration Lab environment, we leverage our technical expertise to explore future capabilities vital to the U.S. national security mission. Vibrint is based in Annapolis Junction, Maryland.

For more information, visit [www.vibrint.com].

About Spencer Fane

Spencer Fane is a full-service business law firm focused on providing results that move clients and their businesses forward. With direct access to firm leadership and a different approach to client engagement, its attorneys instill confidence and certainty that the clients’ interests are the firm’s priority.

For more information, visit [spencerfane.com].

Media Contact
Kelsey O’Shaughnessy
PANBlast for Invary
[email protected]

SOURCE Invary

Pet biotech establishes board of directors, looks ahead to therapies for autoimmune disease, obesity and allergy.

PHILADELPHIA, Feb. 3, 2025 — Vetigenics, a clinical-stage animal health biotechnology company specializing in antibody therapeutics for pets, announces significant progress over the past year, including closing a $6 million seed round and advancing multiple clinical-stage programs.

The investment sets the stage for accelerated growth and value creation for Vetigenics. The funds will be used to advance clinical-stage programs toward pivotal trials, accelerate exciting preclinical candidates, and scale up operations and manufacturing.

“The funding underscores the confidence our investor partners have in our ability to achieve significant progress in a capital-efficient manner,” says Adriann Sax, President, CEO and co-founder of Vetigenics. “They share our belief in the potential of biologics to treat a variety of diseases in pets and the unique capabilities of Vetigenics to stay ahead in this evolving field.”

In addition to this financing success, two major trials using Vetigenics’ antibodies to treat canine cancer have reached key milestones:

• VGS-001 (anti-cCTLA4): The antibody therapy was combined with palliative radiation to treat oral melanoma in dogs. The trial is complete, and encouraging results are expected to be published in 2025.
• VGS-002 (anti-cPD1): The study using VGS-002 as monotherapy in dogs with urothelial carcinoma is nearing completion and promising results are anticipated later this year.

“It is very exciting to see Vetigenics’ checkpoint inhibitors safely addressing significant unmet needs in common veterinary cancers,” says Nicola Mason, BVetMed, PhD, DACVIM, FRCVS, Vetigenics co-founder and clinical investigator.

Vetigenics is also advancing its promising preclinical programs to treat autoimmune disease, obesity and allergy in pets. These therapeutic innovations are expected to address significant unmet needs in companion animal care. In particular, VGS-003 (anti-cCD19 mAb) has been evaluated in vivo and is on track to enter clinical trials by the end of 2025.

“The unique construction of the CANIBODY™ library offers Vetigenics the ability to isolate antibodies to the most challenging targets,” says Don Siegel, PhD, MD, Vetigenics co-founder and researcher.
“To date, our technology has enabled novel antibody generation across therapeutic areas and species in a variety of formats.”

The company has also established a board of directors made up of prominent industry leaders to guide its continued growth:

• Chand Khanna, DVM, PhD, a leader in comparative oncology and translational medicine
• Stephen Lesser, JD, MBA, a seasoned strategic advisor in biotechnology and life sciences
• Caleb Frankel, VMD, an EMR pioneer and tech innovator in the veterinary space
• Adriann Sax, MBA, President, CEO and co- founder of Vetigenics.

With a promising pipeline of clinical trials, new strategic partnerships, and an expanded team of experts, Vetigenics is poised to continue transforming pet health in 2025. The company remains committed to helping pets live their best lives through cutting-edge science and collaborative efforts with partners and supporters.

About Vetigenics
Vetigenics is a clinical-stage animal health biopharmaceutical company committed to advancing targeted antibody therapies for pets from a platform that provides unlimited therapeutic potential. Its proprietary CANIBODY™ technology unlocks faster, more cost-effective, and ethical solutions to develop superior antibodies proven effective in humans with cancer and chronic diseases but created specifically for pets. The company’s innovative technology and pioneering expertise in antibody discovery and development are trusted by global animal health partners and the National Cancer Institute. At Vetigenics, we are dedicated to enabling pets to live their best lives. For more details, visit www.vetigenics.com and connect with us on LinkedIn.

SOURCE Vetigenics

SINGAPORE and LOS ANGELES, Feb. 3, 2025 — Deep-tech startup Nibertex, a pioneer in waterproof breathable membranes, has successfully closed its pre-Series A funding round with participation from Foxmont Capital Partners and ADB Ventures – the impact investment arm of the Asian Development Bank, and other prominent family offices in the region.

The funding will be deployed to ramp up production capacity, enabling Nibertex to meet growing demand from the consumer textiles market while positioning itself for expansion into adjacent sectors such as protective textiles, automotive ventilation, healthcare, and personal protective equipment.

Nibertex’s breakthrough in developing PFAS-free electrospun polyurethane (“ePU”) membranes positions the company as a critical player in addressing this global challenge while delivering eco-conscious solutions to meet consumer and regulatory demands.

PFAS are “forever chemicals” or toxic substances known for their persistence in the environment and links to cancer and other health risks. With bans on PFAS in textiles looming across the EU, California, and New York, global brands are urgently seeking sustainable solutions.

Nibertex’s PFAS-free membranes deliver unmatched waterproofing and breathability performance for textiles. The company has pioneered the scalable production of PFAS-free ePU membranes through its two state-of-the-art manufacturing plants in the Philippines, demonstrating that it can meet global demand while aligning with stricter environmental regulations and standards. These membranes are critical for global brands seeking sustainable, high-performance materials amidst tightening regulatory restrictions on harmful chemicals like PFAS.

“This pre-Series A funding is a testament to the trust our investors place in our technology and the potential of our market,” said Jaemin Park, co-founder of Nibertex. “The demand for sustainable, high-performance materials has never been higher, and this investment allows us to accelerate production and meet the growing needs of our clients across multiple industries.”

Nibertex has seen a surge in orders from global textile brands and is gaining traction in high-value sectors such as firefighter fabrics and professional applications. The company also continues to push the boundaries of electrospinning technology for new applications in mattresses, automotive, and healthcare solutions.

ADB Ventures’ support underscores the importance of finding sustainable alternatives to widely used industrial materials. “Nibertex’s technology supports the global shift towards the use of safer and more sustainable materials,” said Charles Cole Navarro, of ADB Ventures. “By eliminating PFAS and delivering high-performance waterproof breathable membranes, Nibertex is addressing a critical global challenge. We look forward to supporting its growth as it expands beyond textiles into new industries.” 

Jelmer Ikink, Founding Partner at Foxmont Capital Partners said, “We are very happy to have worked closely with ADB Ventures on this round, which highlights proof of Nibertex’s impact. The growth and potential Nibertex has shown over the last quarters have exceeded our expectations, and we are proud to have made a follow-on commitment to fuel Nibertex’s growth.”

The funds will also support Nibertex in scaling production lines at its second facility, expanding R&D efforts for professional textiles, and building capacity to meet future demand in emerging applications.

Having secured this pre-Series A milestone, Nibertex now sets its sights on a Series A round in 2025 to further build out production capacity in response to already existing demand, as it continues to lead the charge in sustainable, high-performance nanofiber technology.

About Nibertex    

Founded in 2019, Nibertex is a deep-tech startup revolutionizing nanofiber technology. With proprietary electrospinning processes, Nibertex produces PFAS-free nanofiber membranes that are lightweight, breathable, and durable. These membranes serve industries spanning technical textiles, healthcare, filtration, automotive, and professional applications.

SOURCE Nibertex